Connect with us

Technology

Eleven Tries to Adjust to SoCal Life in Underwhelming Stranger Things S4 Teaser

Avatar

Published

on

The fourth season of Stranger Things will debut on Netflix in 2022.

It’s Stranger Things Day, marking the anniversary of Will Byers’ mysterious disappearance  (on November 6, 1983) in S1 of the hugely popular Netflix series. The streaming giant is marking the occasion with the release of yet another teaser for S4—and it’s frankly a bit underwhelming.

Netflix has been triclking out teasers for S4 over the last year or so, and tonally, they’ve been all over the place. For instance, the teaser that appeared in May was classic Stranger Things, ominously hinting at the return of Eleven ‘s (Millie Bobby Brown) childhood tormenter and “Papa,” Dr. Martin Brenner (Matthew Modine). Brenner was supposedly killed by the Demogorgon in S1, but there have been mentions of his possible survival. We already knew that David Harbour will be returning as Hopper, along with the rest of the main cast: Winona Ryder, Finn Wolfhard, Natalia Dyer, Noah Schnapp, Charlie Heaton, Joe Keery, Caleb McLaughlin, and Sadie Sink.

We also know it will be the first season to take place largely outside of Hawkins, since Eleven and the Byers have moved away, and Hopper seems to be imprisoned by the Russians. Maya Thurman-Hawke returns as Robin, Brett Gelman will be back as Murray Bauman, Cara Buono returns as the Wheeler matriarch, and we’ll be seeing more of Priah Ferguson, who plays Lucas’ sassy younger sister, Erica. Among the new cast members is Robert Englund of Nightmare on Elm Street fame, which is a nice little link to classic ’80s horror.

Read 3 remaining paragraphs | Comments

Original Article: arstechnica.com

Technology

Truist Sees 350% Upside on This Cancer-Focused Biopharma Stock – Read Why

Avatar

Published

on

Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside.
Analyst Srikripa Devarakonda notes that trading at about 2-times cash, the stock is “undervalued” given its programs in two cancers.
Devarakonda adds that the Verastem base case is supported by a $470 million unadjusted U.S. opportunity in the ovarian cancer program, “early but strong” clinical data, and positive expert feedback.
Related: 

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Technology

“Peek Performance”: Apple’s Next Hardware Event Happens on March 8

Avatar

Published

on

Enlarge (credit: Apple)

Apple will stream its next hardware event to the masses on March 8 at 10 am Pacific (1 pm Eastern), the company announced today. Invitations have already been sent to the press—though the event will be yet another prerecorded, streaming-only presentation with no media in attendance. Apple marketing SVP Greg Joswiak tweeted the now-customary Apple-logo-centric teaser video that doesn’t actually tease anything.

We never know exactly what will be announced at any given Apple event, but Bloomberg’s Mark Gurman reports that the lineup will include a refresh of the budget-friendly iPhone SE and the first iPad Air update in a little over a year.

Rumors have also circulated about updated designs and new Apple Silicon chips for the MacBook Air and the 13-inch MacBook Pro, and the high-end Intel Mac Mini, the 27-inch iMac, and the Mac Pro are all still running Intel chips. The characteristically cryptic “peek performance” tagline does at least hint at new chips for one or more Macs, whether that’s a truly next-gen Apple M2 for thin-and-light laptops or an M1 Pro/Max-focused refresh for the more powerful desktops.

Read 1 remaining paragraphs | Comments

Original Article: arstechnica.com

Continue Reading

Technology

Charles River’s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook

Avatar

Published

on

Charles River Laboratories International Inc’s (NYSE: CRLQ4 sales increased 14.4% Y/Y to $905.1 million, beating the consensus of $888.27 million.

Acquisitions contributed 5.9% to consolidated fourth-quarter revenue growth. Organic revenue growth was 10.5%, driven by contributions from all three business segments. 
Adjusted EPS reached $2.49 higher than $2.39 posted a year ago and …

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Trending

WOC.io